Please provide your email address to receive an email when new articles are posted on . The machine-learning model successfully identified all eyes with mild NPDR that progressed within 1 year. The ...

All eyes are on Eyenuk, now that the Los Angeles-based startup has more than doubled its lifetime fundraising haul and set its sights on bringing its artificial intelligence-powered diagnostic tools ...

Diabetes affects hundreds of millions of people worldwide, and one of its most feared complications is vision loss. High ...

Google has been busy recently. Just in the past week it has closed down its Google Fit website, launched a new drug disposal tool and announced the first clinical use of Verily’s machine learning tool ...

Diabetic retinopathy develops through complex microvascular damage driven by chronic hyperglycemia, yet traditional risk factors such as disease duration or glycemic control explain only part of ...

Empagliflozin, a sodium-glucose cotransporter 2 (SGLT2) inhibitor, did not reduce the risk for incident nonproliferative diabetic retinopathy compared with dipeptidyl peptidase 4 (DPP-4) inhibitors in ...

Non-proliferative diabetic retinopathy is the earliest stage of this diabetes complication. You may not have symptoms, and medical treatments may not be needed aside from diabetes management. As ...

Intraretinal microvascular abnormalities (IRMAs) are abnormal branching, or dilation, of the blood vessels in the retina. It occurs as a complication of diabetic retinopathy. Diabetic retinopathy ...